| 1 |
Aeschbacher-Germann M, Kaiser N, Speierer A, Blum MR, Bauer DC, Del Giovane C, Aujesky D, Gencer B, Rodondi N, Moutzouri E. Lipid-Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta-Analysis of Exclusion Criteria. J Am Heart Assoc 2023;12:e026551. [PMID: 36565207 DOI: 10.1161/JAHA.122.026551] [Reference Citation Analysis]
|
| 2 |
Anderson KM, Murphy D, Groninger H, Kolm P, Wang H, Barton-maxwel V. Perceived symptoms as the primary indicators for 30-day heart failure readmission. PLoS ONE 2022;17:e0267820. [DOI: 10.1371/journal.pone.0267820] [Reference Citation Analysis]
|
| 3 |
Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A, Sousa T. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets. Front Physiol 2021;12:746494. [PMID: 34707513 DOI: 10.3389/fphys.2021.746494] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 4 |
Karami K, Anbari K. Breast Cancer: A Review of Risk Factors and New Insights into Treatment. CCTR 2021;17:207-33. [DOI: 10.2174/1573394717999210120195208] [Reference Citation Analysis]
|
| 5 |
Techorueangwiwat C, Kanitsoraphan C, Hansrivijit P. Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature. F1000Res 2021;10:16. [PMID: 36873456 DOI: 10.12688/f1000research.28254.1] [Reference Citation Analysis]
|
| 6 |
Chen QQ, Wang FX, Cai YY, Zhang YK, Fang JK, Qi LW, Zhang L, Huang FQ. Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling. J Ethnopharmacol 2021;270:113646. [PMID: 33264659 DOI: 10.1016/j.jep.2020.113646] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 7 |
Orekhov AN, Sukhorukov VN, Nikiforov NG, Kubekina MV, Sobenin IA, Foxx KK, Pintus S, Stegmaier P, Stelmashenko D, Kel A, Poznyak AV, Wu WK, Kasianov AS, Makeev VY, Manabe I, Oishi Y. Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First? Int J Mol Sci 2020;21:E2716. [PMID: 32295185 DOI: 10.3390/ijms21082716] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
|
